Disease
Contributors

  • Disrupted energy homeostatis
  • Dysregulated cell death
  • Uncontrolled inflammation

Clinical
Directions

  • Neurodegenerative diseases
  • Inflammatory & immunological diseases
  • Metabolic diseases
  • Rare diseases

Research Project Video Gallery

Explore our latest research initiatives and scientific
breakthroughs through our video presentations.
SARM1

SARM1 Inhibition

Explore the role of SARM1 in axonal degeneration and the therapeutic potential of SARM1 inhibition in neurodegenerative diseases.

Learn More
RIPK1

RIPK1 Inhibition

Studying the role of RIPK1 in regulating cell death and inflammation for novel therapeutic approaches.

Learn More
NAMPT

NAMPT Activation

Explore the critical role of NAMPT in energy homeostasis and the therapeutic potential of NAMPT activator in muscular degenerative diseases.

Learn More

Latest News

Read More
February 6, 2026

Employees Share Their Pride in Accomplishments at Sironax

Read More
November 6, 2025

Sironax Announces Three Abstracts Selected for Presentation at Neuroscience 2025

Read More
October 22, 2025

Sironax Announces Key Leadership Appointments to Advance Global Drug Discovery and Development

Read More
September 19, 2025

Sironax Named to 2025 Endpoints 11 List of the Most Promising Biotech Startups

Read More
July 10, 2025

Comments from Dr. Shefali Agarwal, President and CEO, on Agreement with Novartis

Read More
July 9, 2025

Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery Platform While Retaining Rights to Advance Selected Therapeutic Assets

Read More